These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24156952)

  • 21. [Consensus statement on assistance to women with human immunodeficiency virus infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA)].
    ;
    Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):99.e1-99.e14. PubMed ID: 23896395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
    Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
    Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.
    Kousignian I; Abgrall S; Grabar S; Mahamat A; Teicher E; Rouveix E; Costagliola D;
    Clin Infect Dis; 2008 Jan; 46(2):296-304. PubMed ID: 18171266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
    Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN
    Arch Intern Med; 2006 Mar; 166(5):521-8. PubMed ID: 16534038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Revised guideline "Antiretroviral Treatment"].
    Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Executive summary of the consensus statement on assistance to women with HIV infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA).
    ;
    Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):100-5. PubMed ID: 23931832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Executive summary. Consensus statement of the National AIDS Plan Secretariat, Spanish Society of Emergency Medicine and AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology on Emergency and HIV Infection.
    Expert Panel of the National AIDS Plan Secretariat, Spanish Society of Emergency Medicine and AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology
    Enferm Infecc Microbiol Clin; 2013; 31(7):457-60. PubMed ID: 23601917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.
    Pérez-Molina JA; Martínez E; Blasco AJ; Arribas JR; Domingo P; Iribarren JA; Knobel H; Lázaro P; López-Aldeguer J; Lozano F; Mariño A; Miró JM; Moreno S; Negredo E; Pulido F; Rubio R; Santos J; de la Torre J; Tuset M; von Wichmann MA; Gatell JM
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Mar; 37(3):151-159. PubMed ID: 29884455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of an empirical antiretroviral treatment depends on the primary resistance rate of the human immunodeficiency virus].
    Fernández Gutiérrez Del Álamo C; López Tinoco E; Fernández Rodríguez A; Soto Cárdenas MJ; Lozano Domínguez C; Bernal Martínez S; Guerrero Sánchez F; Girón-González JA
    Enferm Infecc Microbiol Clin; 2012 Nov; 30(9):542-8. PubMed ID: 22365617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan.
    Ribera E; Martínez-Sesmero JM; Sánchez-Rubio J; Rubio R; Pasquau J; Poveda JL; Pérez-Mitru A; Roldán C; Hernández-Novoa B
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Mar; 36(3):157-164. PubMed ID: 28109551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort.
    Suárez-García I; Sobrino-Vegas P; Tejada A; Viciana P; Ribas M; Iribarren J; Díaz Menéndez M; Rivero M; Arazo P; Del Amo J; Moreno S;
    HIV Med; 2014 Feb; 15(2):86-97. PubMed ID: 24007468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
    McArthur JC; McDermott MP; McClernon D; St Hillaire C; Conant K; Marder K; Schifitto G; Selnes OA; Sacktor N; Stern Y; Albert SM; Kieburtz K; deMarcaida JA; Cohen B; Epstein LG
    Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
    Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
    Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan.
    Lee YC; Hung CC; Tsai MS; Zhang JY; Wu PY; Yang SP; Luo YZ; Chang HY; Liu WC; Sun HY; Chang SC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):38-44. PubMed ID: 27329131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiretroviral therapy for HIV infection].
    Lozano F; Domingo P
    Enferm Infecc Microbiol Clin; 2011; 29(6):455-65. PubMed ID: 21489658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
    Chaix ML; Seng R; Frange P; Tran L; Avettand-Fenoël V; Ghosn J; Reynes J; Yazdanpanah Y; Raffi F; Goujard C; Rouzioux C; Meyer L;
    Clin Infect Dis; 2013 Mar; 56(6):880-7. PubMed ID: 23223603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Consensus statement of the National AIDS Plan Secretariat, Spanish Society of Emergency Medicine and AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology on Emergency and Human Immunodeficiency Virus Infection].
    Grupo de Expertos de la Secretaría del Plan Nacional sobre el Sida, de la Sociedad Española de Medicinade Urgencias y Emergencias y del Grupo de Estudio de Sida de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
    Enferm Infecc Microbiol Clin; 2013; 31(7):455.e1-455.e16. PubMed ID: 23601916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.